SCHEMBL23720676

SCHEMBL23720676

CCCCCCC(C)OCC(C)(C)OC

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 5/20 0.36
CA2 P00918 1/20 0.35
CNR1 P21554 1/20 0.35
CNR2 P34972 1/20 0.35
OPRM1 P35372 1/20 0.34
ALDH1A1 P00352 2/20 0.33
TSHR P16473 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
ZDHHC7 Q9NXF8 1/20 0.33
SPHK1 Q9NYA1 1/20 0.33
CA1 P00915 1/20 0.32
LMNA P02545 1/20 0.32
ADH1B P00325 1/20 0.32
ADH1C P00326 1/20 0.32
ADH1A P07327 1/20 0.32
ADH4 P08319 1/20 0.32
ADH7 P40394 1/20 0.32
PLA2G1B P04054 1/20 0.32
PLA2G2A P14555 1/20 0.32
DNM1 Q05193 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24457782 0.79 FAAH (0.40) FAAHCA2CNR1CNR2OPRM1
SCHEMBL24901919 0.77 CA12 (0.33) FAAHCA2ZDHHC7CA1LMNA
SCHEMBL30825390 0.77 FAAH (0.40) FAAHCNR1CNR2OPRM1ALDH1A1
SCHEMBL805998 0.76 FAAH (0.42) FAAHCA2CNR1CNR2ZDHHC7
SCHEMBL28382577 0.76 LMNA (0.42) FAAHCNR1CNR2OPRM1ALDH1A1
SCHEMBL18473603 0.74 CA2 (0.32) FAAHCA2OPRM1CA1DNM1
SCHEMBL24090459 0.73 OPRM1 (0.50) FAAHCNR1CNR2OPRM1ALDH1A1
SCHEMBL3316528 0.73 OPRM1 (0.50) FAAHCNR1CNR2OPRM1ALDH1A1
SCHEMBL22649557 0.73 OPRM1 (0.50) FAAHCNR1CNR2OPRM1ALDH1A1
SCHEMBL471924 0.73 OPRM1 (0.50) FAAHCNR1CNR2OPRM1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210238217-A1 AMIDITE COMPOUND AND METHOD FOR PRODUCING POLYNUCLEOTIDE USING SAID COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2021-08-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210238217-A1 AMIDITE COMPOUND AND METHOD FOR PRODUCING POLYNUCLEOTIDE USING SAID COMPOUND RNMT, REV1, TRDMT1 FAAH 2807/4885CA2 3988/4885CNR1 2307/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.